MRI Guided SBRT for Localized Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2029

Conditions
Prostate Cancer
Interventions
RADIATION

SBRT to whole prostate

Those patients with negative mpMRI prostate scan (PI-RADS 0-2) will receive SBRT (36.25 Gy/5 fractions) to the whole prostate

RADIATION

IMRT followed by mpMRI guided SBRT boost with SIB to intraprostatic lesions

Patients with positive or equivocal mpMRI prostate scan (PI-RADS 3-5) will receive IMRT (45 Gy/25 fractions) to the prostate + seminal vesicles +/- lymph nodes followed by SBRT boost (18 Gy/3 fractions) to the whole prostate with simultaneous integrated boost (21 Gy/3 fractions) to MRI defined intraprostatic lesions

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT03778112 - MRI Guided SBRT for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter